4th European Biosimilars Conference

As the 4th conference of its kind, the 2016 programme gives a complete 360-degree overview of biosimilar medicines. Participants will leave the conference with a wealth of new information and an expanded network of contacts.

Back to Agenda

Session 2: Regulatory Outlook for Other Regions

Session Chair(s)

Julie Marechal-Jamil, MSc

Director, Biosimilar Policy and Science

Medicines For Europe, Belgium

Session 2: Regulatory Outlook for Other Regions

Speaker(s)

WHO Activities in Support of Regulatory Convergence

Ivana Knezevic

World Health Organization, Switzerland

Technical Standards and Specifications Unit (TSS)

Developments Within International Pharmaceutical Regulators Forum

Peter Richardson, PhD

European Medicines Agency, Netherlands

Head of Quality, Specialised Scientific Disciplines Department

US Regulatory Landscape for Biosimilar Medicines

Hillel P Cohen, PhD

Sandoz Inc., United States

Executive Director, Scientific Affairs

International Convergence: An Industry perspective

Cornelia Ulm

Fresenius Kabi, Switzerland

Head of Regulatory Affairs, Biosimilars

Have an account?

4th European Biosimilars Conference

Session 2: Regulatory Outlook for Other Regions

Session Chair(s)

Julie Marechal-Jamil, MSc

Speaker(s)

WHO Activities in Support of Regulatory Convergence

Developments Within International Pharmaceutical Regulators Forum

US Regulatory Landscape for Biosimilar Medicines

International Convergence: An Industry perspective

Be informed and stay engaged.